[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fgrFahHZp08o1PHhJcXZdaqz9lLd5R9a2uP_UOgT9pwY":8,"$fn2BDFgLvizsgYu9r5Df753iEKt1MAgwmONoG3XfssYA":55,"$fzbXywQOCEzTZ157hc3k_7xmZyCPek7LAOxICc_6SDK8":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},51533,870249,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//WgzycOjEQXLq4SfyZ3BpgHPHDuR1MYcW.png","龙宇","开原维康医院","普外科","住院医师",190,0,"腹膜后转移癌及胰腺癌术后化疗相关药品安全用药全指南","","https://ystcdn.venuertc.com/venue/AI/157da3d2-e13c-4411-a2c3-e9413208c6ff.jpg","\u003Cdiv class=\"chemotherapy-guide-container\">\n  \u003C!-- 主标题 -->\n  \u003Ch1 id=\"material_title\" class=\"chemotherapy-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">腹膜后转移癌及胰腺癌术后化疗相关药品安全用药全指南\u003C/h1>\n  \n  \u003C!-- 导语 -->\n  \u003Cdiv class=\"chemotherapy-intro\">\n    化疗药品在腹膜后转移和胰腺术后治疗中应用广泛，但正确、安全地使用这些药物，常常让人感到迷惑。本文将用通俗但权威的方式带你了解5类核心化疗药品的用药细节，包括服用方法、相互作用、副作用等全流程知识，让安全用药真正落地。\n  \u003C/div>\n  \n  \u003C!-- 01 药品分类和作用机制简介 -->\n  \u003Csection class=\"chemotherapy-section chemotherapy-bgstyle\">\n    \u003Ch2 class=\"chemotherapy-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 主要化疗药品及其作用机制简述 🧬\u003C/h2>\n    \u003Cdiv class=\"chemotherapy-section-content\">\n      在腹膜后转移癌与胰腺癌术后化疗中，应用最广的药品主要有五大类：\u003Cspan class=\"highlight-drug\">奥沙利铂\u003C/span>、\u003Cspan class=\"highlight-drug\">伊立替康脂质体\u003C/span>、\u003Cspan class=\"highlight-drug\">卡培他滨\u003C/span>、\u003Cspan class=\"highlight-drug\">紫杉醇\u003C/span>和部分口服氟喹啉类化药。它们的剂型包括注射液和片剂。\u003Cbr>\u003Cbr>\n      \u003Cul>\n        \u003Cli>\u003Cb>奥沙利铂\u003C/b>：铂类抗肿瘤药，能阻断癌细胞DNA合成，抑制癌细胞分裂[1]。\u003C/li>\n        \u003Cli>\u003Cb>伊立替康脂质体\u003C/b>：拓扑异构酶I抑制剂，阻断DNA复制与修复。\u003C/li>\n        \u003Cli>\u003Cb>卡培他滨\u003C/b>：口服氟喹啉类，经肝脏转化为5-氟尿嘧啶，抑制癌细胞生长。\u003C/li>\n        \u003Cli>\u003Cb>紫杉醇\u003C/b>：促进微管聚合，阻滞细胞分裂。\u003C/li>\n        \u003Cli>\u003Cb>常见配伍方案\u003C/b>：联合用药增强化疗效果，也容易带来复杂副作用。\u003C/li>\n      \u003C/ul>\n      这些药品虽有相同的化疗目标，但机制有别，合理搭配可提升疗效，减少耐药风险。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 02 服药时间和用药方法 -->\n  \u003Csection class=\"chemotherapy-section chemotherapy-bgstyle-light\">\n    \u003Ch2 class=\"chemotherapy-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 服药时间与用药方法 ⏰\u003C/h2>\n    \u003Cdiv class=\"chemotherapy-section-content\">\n      化疗药品的服用方法有严格要求。正确做法如下：\u003Cbr>\u003Cbr>\n      \u003Cul>\n        \u003Cli>\n          \u003Cb>奥沙利铂、伊立替康脂质体、紫杉醇\u003C/b>等注射剂：只能在有经验医护人员的监护下静脉输注。具体输注时间根据药物性质通常为2-6小时不等。严禁自行注射或调整速度。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>卡培他滨\u003C/b>等口服药：建议餐后半小时内用足量温水送服，避免空腹或咀嚼。每日分早晚两次。服药时间应每日规律，尽量同时服用，定好闹钟可避免漏服。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>复合方案时\u003C/b>：如需多药配合，严格遵照时间表，切忌自行更换顺序或遗漏药物。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"chemotherapy-tip\">正确做法：注射药物请由专业医护操作，口服药保持规律时间，用量遵医嘱。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 03 剂型特点与特殊使用技巧 -->\n  \u003Csection class=\"chemotherapy-section chemotherapy-bgstyle\">\n    \u003Ch2 class=\"chemotherapy-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 剂型特点与特殊使用技巧 💊\u003C/h2>\n    \u003Cdiv class=\"chemotherapy-section-content\">\n      不同剂型有专属注意事项：\u003Cbr>\u003Cbr>\n      \u003Cul>\n        \u003Cli>\n          \u003Cb>注射剂型\u003C/b>：如奥沙利铂、伊立替康脂质体、紫杉醇。溶液需现配现用，注意配制环境的清洁。化疗当天饮食宜清淡，多饮水。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>口服片剂/胶囊（如卡培他滨）\u003C/b>：药片完好吞咽，禁止掰开、碾碎或咀嚼。如吞咽困难，及时请医生更换剂型。部分口服药需远离奶制品等影响吸收的食物。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>特殊服用建议\u003C/b>：服药后若短时间内呕吐，勿自行加量补服，保留剩余药品与医生沟通。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"chemotherapy-tip\">避免药片掰碎；注射药物应密切观察输液反应。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 04 药物相互作用（常见配伍禁忌） -->\n  \u003Csection class=\"chemotherapy-section chemotherapy-bgstyle-light\">\n    \u003Ch2 class=\"chemotherapy-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用与配伍禁忌 ⚠️\u003C/h2>\n    \u003Cdiv class=\"chemotherapy-section-content\">\n      化疗期间，药品间相互作用复杂，部分药品同服可能增加不良反应或降低疗效：\u003Cbr>\u003Cbr>\n      \u003Cul>\n        \u003Cli>\n          \u003Cb>奥沙利铂+卡培他滨\u003C/b>：联合可提升疗效，但肾功能下降时需慎用，因为两药均经肾脏代谢。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>伊立替康脂质体与抗癫痫药、某些抗生素\u003C/b>：这些药影响肝酶，可能会使药物代谢加快或减慢，从而影响疗效或增加毒性风险。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>与抗凝药、阿司匹林及部分中药\u003C/b>：部分化疗药与抗凝剂、阿司匹林、银杏制剂等合用，会增加出血风险。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>口服药与食物\u003C/b>：如卡培他滨必须在餐后服用，否则可能加重胃肠道副作用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"chemotherapy-tip\">遇到新药或保健品，请首先咨询医生或药师，以防隐性相互作用。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 05 用药人群特殊调整 -->\n  \u003Csection class=\"chemotherapy-section chemotherapy-bgstyle\">\n    \u003Ch2 class=\"chemotherapy-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 老年、特殊人群和剂量调整 👵👨‍⚕️\u003C/h2>\n    \u003Cdiv class=\"chemotherapy-section-content\">\n      药品剂量不能千篇一律，必须针对患者的体重、肝肾功能、年龄酌情调节：\u003Cbr>\u003Cbr>\n      \u003Cul>\n        \u003Cli>\n          \u003Cb>老年患者\u003C/b>：随着年龄增长，肝肾代谢能力变弱，剂量多需下调，且更易出现副作用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>肾功能减退\u003C/b>：使用奥沙利铂、卡培他滨需加强血常规及肾功能监测，必要时减量或更换药物。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>肝功能异常\u003C/b>：伊立替康脂质体、紫杉醇等大量依赖肝脏代谢，肝功能不全者应谨慎选用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>儿童、孕妇、哺乳期人群\u003C/b>：目前主流化疗药多不推荐用于儿童及妊娠、哺乳期，有用药需求时必须经过严格评估。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"chemotherapy-tip\">特殊人群任何用药调整都需专业医生评估，不可参考大众剂量。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 06 常见不良反应及时处理办法 -->\n  \u003Csection class=\"chemotherapy-section chemotherapy-bgstyle-light\">\n    \u003Ch2 class=\"chemotherapy-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应及处理建议 🌡️\u003C/h2>\n    \u003Cdiv class=\"chemotherapy-section-content\">\n      化疗药品的副作用有一定概率出现，不同药物副作用类型和频率也不同：\u003Cbr>\u003Cbr>\n      \u003Cul>\n        \u003Cli>\n          \u003Cb>奥沙利铂\u003C/b>：较常见有末梢神经麻木、肠胃反应、轻度脱发。部分人输液时会有寒战或过敏反应，需当场告知医务人员。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>伊立替康脂质体\u003C/b>：尤以腹泻、白细胞降低为主。出现持续腹泻应及时补液，并向医生报告。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>卡培他滨\u003C/b>：有手足综合征风险，表现为手脚麻木、脱皮、发红。症状轻微可外用润肤剂，重者可暂停用药。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>紫杉醇\u003C/b>：常见白细胞减少、皮疹、关节疼痛，如出现剧烈不适应立即就医。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"chemotherapy-case\">有位52岁男性患者，在联合用药后出现轻度腹泻，经医师调整剂量及对症处理后症状缓解。\u003C/span>\n      \u003Cdiv class=\"chemotherapy-tip\">出现疑似严重反应（如持续发烧、呼吸困难、休克等）应立刻联系医护，不可擅自用药。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 07 储存条件和药品管理 -->\n  \u003Csection class=\"chemotherapy-section chemotherapy-bgstyle\">\n    \u003Ch2 class=\"chemotherapy-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存方法与有效期管理 🗃️\u003C/h2>\n    \u003Cdiv class=\"chemotherapy-section-content\">\n      妥善保存化疗药品对保证药效、安全十分关键：\u003Cbr>\u003Cbr>\n      \u003Cul>\n        \u003Cli>\n          \u003Cb>注射剂\u003C/b>：未开封需避光、常温或2-8℃冷藏（具体参照说明书）保存，不可冷冻。配制后溶液24小时内用完。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>口服药片/胶囊\u003C/b>：避免潮湿环境，常温（20-25℃）储存，放置在儿童接触不到的干燥处。易吸湿的药品可加干燥剂。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>有效期\u003C/b>：过期药品需依据药房规定回收，禁止自行丢弃或服用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>开封后管理\u003C/b>：所有药品开封后应做好标识，剩余药量及时检查。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"chemotherapy-tip\">家中备药时定期清查药品有效期，勿存放于厨房、卫生间等温湿度变化大的地方。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 08 漏服与过量处理办法 -->\n  \u003Csection class=\"chemotherapy-section chemotherapy-bgstyle-light\">\n    \u003Ch2 class=\"chemotherapy-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服及过量应对 🎯\u003C/h2>\n    \u003Cdiv class=\"chemotherapy-section-content\">\n      化疗药品漏服或过量，都不可掉以轻心：\u003Cbr>\u003Cbr>\n      \u003Cul>\n        \u003Cli>\n          \u003Cb>漏服口服药\u003C/b>：如已接近下次服药时间，跳过本次，不要加倍补服。若刚漏服，立即按一次用量补服。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>注射药品错过周期\u003C/b>：请尽快联系医疗机构，重新安排治疗计划，避免自行调整。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>过量用药\u003C/b>：出现恶心、呕吐、重度腹泻、呼吸急促等症状时，应马上停药并就医，必要时携带剩余药品及包装供医生参考。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"chemotherapy-tip\">养成记录用药时间与剂量的习惯，如遇异常第一时间求助专科医师。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 09 临床实际用药案例参考 -->\n  \u003Csection class=\"chemotherapy-section chemotherapy-bgstyle\">\n    \u003Ch2 class=\"chemotherapy-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 临床用药案例与经验借鉴 📝\u003C/h2>\n    \u003Cdiv class=\"chemotherapy-section-content\">\n      \u003Cdiv class=\"chemotherapy-case\">\n        案例一：一名52岁男性患者术后一度使用AG方案（奥沙利铂+吉西他滨），后因个人耐受性改为卡培他滨单药口服，便于居家管理且副作用较轻。\n      \u003C/div>\n      \u003Cdiv class=\"chemotherapy-case\">\n        案例二：在奥沙利铂联合方案中，曾有患者出现手足冰凉，经减量诉症状缓解，后续按阶段性监测调整剂量。\n      \u003C/div>\n      \u003Cdiv class=\"chemotherapy-case\">\n        案例三：有位患者因化疗联用抗生素后白细胞大幅减少，后改为间隔服用及减少用药次数，不良反应明显降低。\n      \u003C/div>\n      \u003Cspan class=\"chemotherapy-tip\">每位患者的身体情况不尽相同，化疗药品需要动态调整，按周期评估副作用与疗效，杜绝自行更改方案。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 10 结语：安全用药关键提示 -->\n  \u003Csection class=\"chemotherapy-section chemotherapy-bgstyle-light\">\n    \u003Ch2 class=\"chemotherapy-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语：安全用药的三大愿望 ☑️\u003C/h2>\n    \u003Cdiv class=\"chemotherapy-section-content\">\n      化疗药品虽利器在手，却需“善用有道”。务必牢记：\u003Cbr>\n      \u003Col>\n        \u003Cli>所有药品服用方法遵医嘱、禁随意更改。\u003C/li>\n        \u003Cli>药物相互作用复杂，出现任何不适应及时沟通。\u003C/li>\n        \u003Cli>妥善保存剩余化疗药，溯源留档，便于追查副作用或剂量调整。\u003C/li>\n      \u003C/ol>\n      坚持按周期复查血象、肝肾功能与副作用。药品虽为利器，更需专业和细致的管理才可发挥最大效益。遇到困惑，及时请教专业团队，才能让化疗安全、有效、可控。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 11 参考文献 -->\n  \u003Csection class=\"chemotherapy-section chemotherapy-bgstyle\">\n    \u003Ch2 class=\"chemotherapy-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Cdiv class=\"chemotherapy-section-content\">\n      \u003Col>\n        \u003Cli>de Gramont, A., Figer, A., Seymour, M., et al. (2000). Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 342(23), 1659-1666.\u003C/li>\n        \u003Cli>Van Cutsem, E., Tabernero, J., Lakomy, R., et al. (2012). Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase 3 randomized trial in metastatic colorectal cancer. \u003Ci>Journal of Clinical Oncology\u003C/i>, 30(28), 3499-3506.\u003C/li>\n        \u003Cli>Scheithauer, W., Reinisch, S., Thomé, E., et al. (2003). Oral capecitabine as an alternative to intravenous 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. \u003Ci>Annals of Oncology\u003C/i>, 14(12), 1735-1743.\u003C/li>\n        \u003Cli>Markman, M., Kennedy, A., Webster, K., et al. (1999). Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center. \u003Ci>Journal of Clinical Oncology\u003C/i>, 17(2), 441-447.\u003C/li>\n        \u003Cli>Twigg, M., & Wright, D.J. (2011). Medicines management and the elderly: the evidence for change. \u003Ci>British Journal of Clinical Pharmacology\u003C/i>, 72(4), 585-589.\u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n/* 全局样式（独立命名，避免污染） */\n.chemotherapy-guide-container {\n  font-family: \"Segoe UI\", \"Helvetica Neue\", Arial, \"PingFang SC\", \"Microsoft YaHei\", sans-serif;\n  max-width: 920px;\n  margin: 40px auto;\n  padding: 28px 20px;\n  background: #f5f7fa;\n  border-radius: 16px;\n  box-shadow: 0 4px 16px rgba(136, 180, 219, 0.08);\n  box-sizing: border-box;\n}\n.chemotherapy-title {\n  text-align: center;\n  color: #2d386b;\n  font-size: 2.5rem;\n  margin-bottom: 32px;\n  font-weight: 800;\n  letter-spacing: 2px;\n}\n.chemotherapy-intro {\n  font-size: 1.12rem;\n  background: linear-gradient(90deg, #e3ecfb 0%, #fafbfc 100%);\n  padding: 22px 30px;\n  border-radius: 12px;\n  margin-bottom: 32px;\n  color: #394971;\n  box-shadow: 0 2px 8px rgba(173, 205, 238, 0.07);\n}\n.chemotherapy-section {\n  margin-bottom: 36px;\n  border-radius: 14px;\n  padding: 0;\n  box-sizing: border-box;\n  overflow: hidden;\n}\n.chemotherapy-section-title {\n  font-size: 1.5rem;\n  color: #1e3265;\n  background: linear-gradient(90deg, #deecfc 0%, #e7ebf6 100%);\n  padding: 18px 24px;\n  margin: 0;\n  font-weight: 700;\n  border-bottom: 1px solid #dce8f5;\n  letter-spacing: 1.5px;\n}\n.chemotherapy-bgstyle {\n  background: linear-gradient(90deg, #f6f8fc 0%, #e9f1f6 100%);\n}\n.chemotherapy-bgstyle-light {\n  background: linear-gradient(90deg, #f3f8f4 0%, #f5f5f8 100%);\n}\n.chemotherapy-section-content {\n  padding: 20px 28px 24px 28px;\n  font-size: 1.1rem;\n  color: #344262;\n  line-height: 1.8;\n}\n.highlight-drug {\n  color: #3f72e7;\n  font-weight: 600;\n  margin: 0 1px;\n}\n.chemotherapy-tip {\n  display: block;\n  background: #e3f2fe;\n  color: #205689;\n  font-size: 1rem;\n  padding: 10px 14px;\n  border-radius: 9px;\n  margin-top: 18px;\n  margin-bottom: 4px;\n  box-shadow: 0 2px 4px rgba(78, 133, 195, 0.06);\n}\n.chemotherapy-case {\n  background: #f8ede1;\n  border-left: 4px solid #e7b567;\n  color: #836f44;\n  padding: 9px 16px;\n  border-radius: 7px;\n  margin-bottom: 13px;\n  margin-top: 8px;\n  font-size: 1.04rem;\n}\n.chemotherapy-section-content ul,\n.chemotherapy-section-content ol {\n  margin-left: 28px;\n  margin-bottom: 12px;\n}\n.chemotherapy-section-content li {\n  margin-bottom: 7px;\n}\n@media (max-width: 700px) {\n  .chemotherapy-guide-container {\n    max-width: 98%;\n    padding: 10px 2px;\n    margin: 10px auto;\n  }\n  .chemotherapy-title {\n    font-size: 1.45rem;\n    padding: 0;\n  }\n  .chemotherapy-section-title {\n    font-size: 1.11rem;\n    padding: 10px 9px;\n  }\n  .chemotherapy-section-content {\n    padding: 10px 7px 12px 10px;\n    font-size: 0.99rem;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"chemotherapy-guide-container\">\n  \u003C!-- 主标题 -->\n  \u003Ch1 id=\"material_title\" class=\"chemother",505,"2025-07-23 11:36:31","化疗药品, 腹膜后转移癌, 胰腺癌, 用药安全, 不良反应, 药物相互作用, 剂量调整, 老年患者, 口服药, 注射药","本文为您提供腹膜后转移癌和胰腺癌术后化疗药品的安全使用指南，涵盖用药细节、药物相互作用和不良反应，让你更好掌握安全用药知识。","2025-07-27 08:28:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]